A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC
Clinical trial NCT03732001 · UNKNOWN
Trial details
- NCT number
- NCT03732001
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2019-11-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.